hotspot -WSS

hotspot

author：knowledge 2025-10-02 15:44:09 - browse：768

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Dementia risk linked to living in disadvantaged areas: Study

hotspot

explore

WSS

There’s a way to spot data fakery. All journals should be using it

Republicans love RFK Jr. What's that tell us about health in 2024?

Delta passengers in Vegas fall sick while waiting on flight in triple

PBMs are inflating the cost of generic drugs. They must be reined in

When a patient nears the end, a feared therapy can comfort

California store owner shot dead in dispute over displaying Pride flag: Police

focus

hotspot

hotspot

Virginia high school admissions case could be legal follow

How to make over

Wildfire smoke exposes gaps in outdoor worker protections

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Activists slam private health insurers over coverage restrictions

Hospital at home shows how to bring innovation to health care

Virginia high school admissions case could be legal follow

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Activists slam private health insurers over coverage restrictions

FDA advisory panel to debate high blood pressure devices

hotspot

Vivek Ramaswamy made waves in the debate, much as in biotech

When a patient nears the end, a feared therapy can comfort

5 dead in mass shooting on Caribbean island of St. Vincent: Police

US jobless claims fall again as labor market continues to flash strength

Caribou posts encouraging results on off

Kellogg’s is going to war over Mexico’s nutrition label rules

explore

hotspot

explore

explore